X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
breast cancer (20) 20
humans (16) 16
female (15) 15
middle aged (13) 13
aged (12) 12
oncology (12) 12
adult (11) 11
breast neoplasms - drug therapy (11) 11
breast neoplasms - pathology (10) 10
index medicus (10) 10
chemotherapy (8) 8
double-blind method (7) 7
metastasis (7) 7
postmenopausal women (7) 7
treatment outcome (7) 7
aged, 80 and over (6) 6
care and treatment (6) 6
neoplasm staging (6) 6
patients (6) 6
survival (6) 6
trastuzumab (6) 6
antineoplastic combined chemotherapy protocols - therapeutic use (5) 5
breast neoplasms - metabolism (5) 5
breast neoplasms - mortality (5) 5
disease-free survival (5) 5
drug administration schedule (5) 5
endocrine therapy (5) 5
research (5) 5
tamoxifen (5) 5
tumors (5) 5
analysis (4) 4
antineoplastic agents - therapeutic use (4) 4
cancer therapies (4) 4
clinical trials (4) 4
combination (4) 4
double-blind (4) 4
follow-up studies (4) 4
kaplan-meier estimate (4) 4
lapatinib (4) 4
postmenopause (4) 4
prognosis (4) 4
proportional hazards models (4) 4
receptor, erbb-2 - metabolism (4) 4
receptors, estrogen - metabolism (4) 4
survival analysis (4) 4
survival rate (4) 4
womens health (4) 4
anastrozole (3) 3
angiogenesis inhibitors (3) 3
antibodies, monoclonal, humanized (3) 3
antineoplastic combined chemotherapy protocols - administration & dosage (3) 3
breast neoplasms - surgery (3) 3
development and progression (3) 3
dose-response relationship, drug (3) 3
erbb-2 protein (3) 3
estrogen (3) 3
everolimus (3) 3
health aspects (3) 3
hematology, oncology and palliative medicine (3) 3
internal medicine (3) 3
mastectomy - methods (3) 3
medical colleges (3) 3
medical prognosis (3) 3
medicine & public health (3) 3
medicine, general & internal (3) 3
metastases (3) 3
metastatic breast cancer (3) 3
neoadjuvant chemotherapy (3) 3
palbociclib (3) 3
postmenopausal (3) 3
receptors, progesterone - metabolism (3) 3
therapy (3) 3
trastuzumab - adverse effects (3) 3
trial (3) 3
abridged index medicus (2) 2
advanced breast cancer (2) 2
androstadienes - administration & dosage (2) 2
anthracycline (2) 2
antibodies, monoclonal - therapeutic use (2) 2
antimitotic agents (2) 2
antineoplastic agents (2) 2
antineoplastic agents - adverse effects (2) 2
antineoplastic combined chemotherapy protocols - adverse effects (2) 2
aromatase inhibitors (2) 2
bevacizumab (2) 2
breast neoplasms - secondary (2) 2
cancer (2) 2
cardiology (2) 2
cardiotoxicity (2) 2
chemotherapy, adjuvant (2) 2
confidence intervals (2) 2
diagnosis (2) 2
disease progression (2) 2
endocrinology (2) 2
estrogen receptor (2) 2
estrogen-receptor (2) 2
exemestane (2) 2
further section · weitere sektionen (2) 2
gene mutations (2) 2
guidelines (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet, The, ISSN 0140-6736, 2011, Volume 377, Issue 9769, pp. 914 - 923
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2016, Volume 17, Issue 3, pp. 367 - 377
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2016, Volume 17, Issue 6, pp. 811 - 821
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 11/2016, Volume 375, Issue 18, pp. 1738 - 1748
Journal Article
by Martin, Miguel and Holmes, Frankie A and Ejlertsen, Bent and Delaloge, Suzette and Moy, Beverly and Iwata, Hiroji and von Minckwitz, Gunter and Chia, Stephen K L and Mansi, Janine and Barrios, Carlos H and Gnant, Michael and Tomašević, Zorica and Denduluri, Neelima and Šeparović, Robert and Gokmen, Erhan and Bashford, Anna and Ruiz Borrego, Manuel and Kim, Sung-Bae and Kim, Seung Jin and Jakobsen, Erik Hugger and Ciceniene, Audrone and Inoue, Kenichi and Overkamp, Friedrich and Heijns, Joan B and Armstrong, Anne C and Link, John S and Joy, Anil Abraham and Bryce, Richard and Wong, Alvin and Moran, Susan and Yao, Bin and Xu, Feng and Xu, Binghe and Auerbach, Alan and Buyse, Marc and Chan, Arlene and Harvey, Vernon and Tomek, Rudolf and Robert, Nicholas J and Gore, Ira and Smith, John W and Smith, Julie C and Masuda, Norikazu and Di Sean Kendall, S and Harker, William Graydon and Petrakova, Katarina and Guerrero Zotano, Angel and Simon, Amparo Ruiz and Konstantinovic, Zora Neskovic and Iannotti, Nicholas O and Tassone, Pierfrancesco and Rodriguez, Gladys I and Jáñez Martinez, Noelia and Crespo Massieu, Carmen and Smickoska, Snezana and Somali, Isil and Yilmaz, Ugur and Alonso, Mirta Garcia and Rosales, Adolfo Murias and Cold, Soeren and Knoop, Ann Soegaard and Patt, Debra and Hellerstedt, Beth A and Morales Murillo, Serafin and Mayer, Ingrid A and Means-Powell, Julie Ann and Hui, Rina and Senecal, Francis M and De Boer, Richard Hendry and Shen, Zhenzhou and Luczak, Adam Andrzej and Chui, Joanna W.Y and Chui, Stephen and Tsang, Janice Wing-hang and Lang, Istvan and Rai, Yoshiaki and Hozumi, Yasuo and Ten Tije, Albert J and Bhandari, Manish and Osborne, Cynthia R.C and Ohtani, Shoichiro and Higaki, Kenji and Watanabe, Junichiro and Watanabe, Kenichi and Taguchi, Tetsuya and Taguchi, Kazunori and Takahashi, Masato and Filipovic, Sladjana and Hansen, Vincent L and Rao, Vijayarama Phooshkooru and Gupta, Manish and Petrov, Petar and Coudert, Bruno and Vojnovic, Zeljko and Polya, Zsofia and Miyaki, Toshiko and Yamamoto, Naohito and Brincat, Stephen and Lesniewski-Kmak, Krzysztof and Chmielowska, Ewa and ... and ExteNET Study Grp and ExteNET Study Group
The Lancet Oncology, ISSN 1470-2045, 12/2017, Volume 18, Issue 12, pp. 1688 - 1700
Journal Article
Breast Cancer Research and Treatment, ISSN 0167-6806, 2/2018, Volume 168, Issue 1, pp. 127 - 134
Journal Article
Journal Article
International Journal of Clinical Practice, ISSN 1368-5031, 09/2018, Volume 72, Issue 9, pp. e13235 - n/a
Background and Purpose: Appropriate surveillance guidelines for patients after successful treatment of Hodgkin's lymphoma (HL) are needed to reduce mortality... 
TRIALS | MEDICINE, GENERAL & INTERNAL | DISEASE | GUIDELINES | RISK | RADIOTHERAPY | INHIBITORS | RADIATION-THERAPY | Chemotherapy | Analysis | Leukemia | Lung cancer | Oncology, Experimental | Mortality | Lymphomas | Research | Radiotherapy | Skin cancer | Cancer | Medical research | Hematology | Radiation | Clinical trials | Risk | Malignancy | Radiation therapy | Patients | Lymphoma | Breast carcinoma | Skin | Combined treatment
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 08/2018, Volume 36, Issue 24, pp. 2465 - 2472
PurposeThis phase III study evaluated ribociclib plus fulvestrant in patients with hormone receptor-positive/human epidermal growth factor receptor 2-negative... 
TRIAL | DOUBLE-BLIND | PALBOCICLIB | ENDOCRINE THERAPY | ONCOLOGY | TUMORS
Journal Article
Advances in Therapy, ISSN 0741-238X, 10/2013, Volume 30, Issue 10, pp. 870 - 884
Journal Article